EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma

Laura Sánchez-Sánchez iD, Javier García, Roberto Fernández iD, Ekaterina Noskova, June Egiguren-Ortiz, Marina Gulak, Eneko Ochoa, Antonio Laso, Mikel Oiarbide iD, José Ignacio Santos iD, María Fe Andrés iD, Azucena González-Coloma iD und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043837 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Laura Sánchez-Sánchez und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain. Hauptthemen laut MEDLINE: Cannabis, Neuroblastoma, Plant Extracts. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Economy and Competitiveness, Basque Government Department of Economic Development, Sustainability and Environment.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabis has been used for decades as a palliative therapy in the treatment of cancer. This is because of its beneficial effects on the pain and nausea that patients can experience as a result of chemo/radiotherapy. Tetrahydrocannabinol and cannabidiol are the main compounds present in Cannabis sativa, and both exert their actions through a receptor-mediated mechanism and through a non-receptor-mediated mechanism, which modulates the formation of reactive oxygen species. These oxidative stress conditions might trigger lipidic changes, which would compromise cell membrane stability and viability. In this sense, numerous pieces of evidence describe a potential antitumor effect of cannabinoid compounds in different types of cancer, although controversial results limit their implementation. In order to further investigate the possible mechanism involved in the antitumoral effects of cannabinoids, three extracts isolated from Cannabis sativa strains with high cannabidiol content were analyzed. Cell mortality, cytochrome c oxidase activity and the lipid composition of SH-SY5Y cells were determined in the absence and presence of specific cannabinoid ligands, with and without antioxidant pre-treatment. The cell mortality induced by the extracts in this study appeared to be related to the inhibition of the cytochrome c oxidase activity and to the THC concentration. This effect on cell viability was similar to that observed with the cannabinoid agonist WIN55,212-2. The effect was partially blocked by the selective CB1 antagonist AM281, and the antioxidant α-tocopherol. Moreover, certain membrane lipids were affected by the extracts, which demonstrated the importance of oxidative stress in the potential antitumoral effects of cannabinoids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabisNeuroblastomaPlant ExtractsHumansCannabidiolCannabinoidsDronabinolElectron Transport Complex IV

Stichwörter der Autor:innen

antitumorcannabisextractsneuroblastoma

Substanzen

CannabidiolCannabinoidsDronabinolElectron Transport Complex IVPlant Extracts

Autor:innen und Institutionen

  • Research and Development Department, IMG Pharma Biotech S.L., 48160 Derio, Spain.
  • Instituto de Biología y Genética Molecular (IBGM), Unidad de Excelencia, Universidad de Valladolid-CSIC, 47011 Valladolid, Spain.
  • Institute of Agricultural Sciences (ICA), Spanish Research Council (CSIC), 28006 Madrid, Spain.
  • Instituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Consejo Superior de Investigaciones Científicas (CSIC), University of Cantabria, 39011 Santander, Spain.
  • Pharmacology Department, Faculty of Medicine and Nursing, University of the Basque Country UPV/EHU, 48940 Leioa, Spain.
  • Cruz Roja Hospital, 48001 Bilbao, Spain.

ORCID-Profile: Laura Sánchez-Sánchez, Roberto Fernández, Mikel Oiarbide, José Ignacio Santos, María Fe Andrés, Azucena González-Coloma, Albert Adell, Egoitz Astigarraga, Gabriel Barreda-Gómez

Förderung

  • Ministry of Economy and Competitiveness
  • Basque Government Department of Economic Development, Sustainability and Environment

Zitieren

APA

Sánchez-Sánchez, L., García, J., Fernández, R., Noskova, E., Egiguren-Ortiz, J., Gulak, M., Ochoa, E., Laso, A., Oiarbide, M., Santos, J. I., Fe Andrés, M., González-Coloma, A., Adell, A., Astigarraga, E., & Barreda-Gómez, G. (2023). Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043837

Vancouver

Sánchez-Sánchez L, García J, Fernández R, Noskova E, Egiguren-Ortiz J, Gulak M, et al. Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043837

BibTeX
@article{SnchezSnchez2023,
  author = {Sánchez-Sánchez, Laura and García, Javier and Fernández, Roberto and Noskova, Ekaterina and Egiguren-Ortiz, June and Gulak, Marina and Ochoa, Eneko and Laso, Antonio and Oiarbide, Mikel and Santos, José Ignacio and Fe Andrés, María and González-Coloma, Azucena and Adell, Albert and Astigarraga, Egoitz and Barreda-Gómez, Gabriel},
  title = {Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043837}
}
Kostenlos starten →